Mark Ross

1.8k citations
43 papers · 1.1k indexed · h-index 20

Mark Ross

41 papers receiving 1.0k citations

Peers

Mark Ross
Comparison fields: 5 of 118
  • Rehabilitation 79
  • Hematology 97
  • Complementary and alternative medicine 70
  • Cardiology and Cardiovascular Medicine 171
  • Oncology 188
Replace Griselda A. Cabral-Pacheco with:
Griselda A. Cabral-Pacheco Mexico
Smriti M. Krishna Australia
Shinichi Kanno Japan
Jian Jia China
Elena Masselli Italy
Alexandros Kortsaris Greece
Olga Tura-Ceide Spain
Chien‐Chung Huang Taiwan
Maria Pagano Italy
Mark Ross relative to Griselda A. Cabral-Pacheco Mexico Griselda A. Cabral-Pacheco's profile →
Citations per field
00.5×10×20×31×
Griselda A. Cabral-Pacheco · 1×
Citations per year

Countries citing papers authored by Mark Ross

Since Specialization
Citations

This map shows the geographic impact of Mark Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ross more than expected).

Fields of papers citing papers by Mark Ross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ross. The network helps show where Mark Ross may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Ross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Ross Line = papers co-authored together Mark Ross links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20241
3 202364
4 20230
5 20222
6 20221
7 20216
8 202115
9 20206
10 202012
11 202030
12 201917
13 201919
14 201918
15 201485
16 201426
17 200133
18 199864
19 199830
20 199624

About Mark Ross

Mark Ross is a scholar working on Rehabilitation, Complementary and alternative medicine and Internal Medicine, having authored 43 papers that have together received 1.1k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (9 papers), Exercise and Physiological Responses (9 papers), Cardiovascular and exercise physiology (7 papers), Lymphatic System and Diseases (5 papers), Adipose Tissue and Metabolism (4 papers), Cardiovascular Disease and Adiposity (3 papers), Cardiovascular Health and Disease Prevention (3 papers) and Muscle metabolism and nutrition (2 papers). The work is most often cited by research in Rehabilitation (79 citations), Hematology (97 citations) and Complementary and alternative medicine (70 citations). Mark Ross has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Geraint Florida‐James, Eva Malone, Michael Harrison, John P. Phelan, Georgina M. Ellison, Thomas A. Agbaedeng, Henning Wackerhage, Jack Leslie, Samuel T. Orange and Derek A. Mann. Their work appears in journals such as European Journal of Applied Physiology, Scientific Reports, European Journal of Cardiovascular Nursing, Genomics and Frontiers in Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026